<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; NEW DRUGS</title>
	<atom:link href="http://annpharmacy.com/blog/category/new-drugs/feed" rel="self" type="application/rss+xml" />
	<link>http://annpharmacy.com/blog</link>
	<description>Health, Diseases, Drugs &#38; medications, Online canadian pharmacy</description>
	<lastBuildDate>Wed, 25 May 2011 13:02:23 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Antioxidants for the Critically Ill: Better Sooner Than Later</title>
		<link>http://annpharmacy.com/blog/new-drugs/antioxidants-for-the-critically-ill-better-sooner-than-later.html</link>
		<comments>http://annpharmacy.com/blog/new-drugs/antioxidants-for-the-critically-ill-better-sooner-than-later.html#comments</comments>
		<pubDate>Tue, 24 May 2011 13:02:23 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[NEW DRUGS]]></category>
		<category><![CDATA[Antioxidants]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=1633</guid>
		<description><![CDATA[Giving critically ill patients supplemental antioxidants before they appear to need them can help keep organs from failing, say researchers from Harborview Medical Center in Seattle, Washington. Of 595 patients, 310 were randomly assigned to receive alpha-tocopherol and ascorbate and 294 were assigned to standard care. By day 28, 44 (15%) of the patients receiving [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/new-drugs/antioxidants-for-the-critically-ill-better-sooner-than-later.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Tool for Hospital Pharmacies</title>
		<link>http://annpharmacy.com/blog/new-drugs/new-tool-for-hospital-pharmacies.html</link>
		<comments>http://annpharmacy.com/blog/new-drugs/new-tool-for-hospital-pharmacies.html#comments</comments>
		<pubDate>Sun, 22 May 2011 13:02:20 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[NEW DRUGS]]></category>
		<category><![CDATA[Hospital Pharmacies]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=1637</guid>
		<description><![CDATA[The Formulary Advisor™ is a new product that is expected to simplify the development and management of online formularies in hospitals. It allows prescribing clinicians to view, create, manage, and update a complete formulary on a desktop or laptop computer or on a personal digital assistant (PDA). The device provides immediate access to current information [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/new-drugs/new-tool-for-hospital-pharmacies.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Alteplase: How Low Can a Dose Go</title>
		<link>http://annpharmacy.com/blog/new-drugs/alteplase-how-low-can-a-dose-go.html</link>
		<comments>http://annpharmacy.com/blog/new-drugs/alteplase-how-low-can-a-dose-go.html#comments</comments>
		<pubDate>Wed, 11 May 2011 13:02:05 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[NEW DRUGS]]></category>
		<category><![CDATA[Alteplase]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=1659</guid>
		<description><![CDATA[Alteplase has replaced urokinase as the first choice in restoring blood flow through hemodialysis catheters, but the lowest effective dose has not been established. Reports have documented effectiveness with doses ranging from 2 to 45 mg. cheap evista In a retrospective study of 27 patients given alteplase and 10 given urokinase between June 1997 and [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/new-drugs/alteplase-how-low-can-a-dose-go.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Methadone Link to Torsades de Pointes?</title>
		<link>http://annpharmacy.com/blog/new-drugs/methadone-link-to-torsades-de-pointes.html</link>
		<comments>http://annpharmacy.com/blog/new-drugs/methadone-link-to-torsades-de-pointes.html#comments</comments>
		<pubDate>Tue, 10 May 2011 13:02:04 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[NEW DRUGS]]></category>
		<category><![CDATA[Methadone Link]]></category>
		<category><![CDATA[Torsades]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=1661</guid>
		<description><![CDATA[There is some concern that methadone, used in very high doses, might be linked to torsades de pointes, an atypical form of ventricular tachycardia (rapid heartbeat) that can lead to ventricular fibrillation. Methadone is used in the treatment of opioid dependency and pain. Researchers at Denver Health Medical Center performed a retrospective study of patients [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/new-drugs/methadone-link-to-torsades-de-pointes.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HAART Safe for Patients with HIV and Hepatitis C</title>
		<link>http://annpharmacy.com/blog/new-drugs/haart-safe-for-patients-with-hiv-and-hepatitis-c.html</link>
		<comments>http://annpharmacy.com/blog/new-drugs/haart-safe-for-patients-with-hiv-and-hepatitis-c.html#comments</comments>
		<pubDate>Thu, 05 May 2011 13:01:48 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[NEW DRUGS]]></category>
		<category><![CDATA[HAART Safe]]></category>
		<category><![CDATA[Hepatitis C]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=1671</guid>
		<description><![CDATA[Hepatitis C has no effect on the outcomes of patients with human immunodeficiency virus (HIV) who are treated with highly active antiretroviral therapy (HAART), according to researchers from Johns Hopkins University. The researchers said that the liver infection does not decrease the response to anti-AIDS drugs or speed progression of the illness. The researchers followed [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/new-drugs/haart-safe-for-patients-with-hiv-and-hepatitis-c.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patient-Friendly OTC Labels</title>
		<link>http://annpharmacy.com/blog/new-drugs/patient-friendly-otc-labels.html</link>
		<comments>http://annpharmacy.com/blog/new-drugs/patient-friendly-otc-labels.html#comments</comments>
		<pubDate>Wed, 04 May 2011 13:01:47 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[NEW DRUGS]]></category>
		<category><![CDATA[Patient-Friendly]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=1673</guid>
		<description><![CDATA[As of May 16, 2002, most over-the-counter (OTC) drug manufacturers have begun using &#8220;consumer-friendly&#8221; labeling. The new Drug Facts label—patterned after the Nutrition Facts food label—features simpler language and an easier-to-read format. In addition to a larger type size and other changes to enhance readability, the label must include the drug&#8217;s information in the following [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/new-drugs/patient-friendly-otc-labels.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Age, Not Gender, Bias Found in Heart Attack Study</title>
		<link>http://annpharmacy.com/blog/new-drugs/age-not-gender-bias-found-in-heart-attack-study.html</link>
		<comments>http://annpharmacy.com/blog/new-drugs/age-not-gender-bias-found-in-heart-attack-study.html#comments</comments>
		<pubDate>Tue, 26 Apr 2011 13:01:38 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[NEW DRUGS]]></category>
		<category><![CDATA[Heart Attack]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=1689</guid>
		<description><![CDATA[According to a new study published in the June 19, 2002 issue of the Journal of the American College of Cardiology, the difference in treatment for heart attacks in men and women might be caused by age rather than by gender. celebrex 100 mg The Institute for Clinical Evaluative Sciences in Toronto, Ontario, Canada, studied [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/new-drugs/age-not-gender-bias-found-in-heart-attack-study.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

